Throughout the past year, there have been dramatic announcements from the World Health Organization in regards to cannabis. Most recently the WHO recommended rescheduling cannabis. Not just cannabis but also several of its critical components per international drug treaties. Last month the WHO reports were released and the European Parliament voted on a resolution that may help to progress the availability of cannabis in the EU. Additionally, it could positively reform the legality of medical cannabis in EU countries.
The Resolution Details
The resolution in which they voted on is non-binding. However, it is quite substantial as it shows that the European Parliament is engaging in dialogue regarding cannabis laws locally. The resolution according to Forbes “seeks to incentivize European nations to increase access to medical marijuana, prioritizing scientific research and clinical studies.”
The resolution received a vote by the European Parliament. This was after an evaluation of how the European Union might be able to support quality cannabinoid research. It also calls for the EU to address the “regulatory, financial, and cultural barriers” that prevent such research.
Working with WHO for Quality Research
According to the commission, it is vital that they “define the conditions required to enable credible, independent, scientific research based on a wide range of material to be conducted into the use of cannabis for medicinal purposes.”
The resolution also calls for the EU to work in close collaboration with the World Health Organization. In addition, it states that it is essential that they’re provided with “comprehensive information about the full spectrum profiles of the plant strains used in the medication provided.”
While this resolution doesn’t change any current local or national laws pertaining to cannabis, it is opening up some much-needed dialogue. Dialogue amongst political parties that could result in substantial scientific discoveries. Not just discoveries but also a significant increase in the number of European residents that can legally access and utilize cannabis for medicinal purposes.